BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8084454)

  • 1. Nocturnal intermittent peritoneal dialysis.
    Woodrow G; Turney JH; Cook JA; Gibson J; Fletcher S; Stewart AJ; Brownjohn AM
    Nephrol Dial Transplant; 1994; 9(4):399-403. PubMed ID: 8084454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis?
    Cueto-Manzano AM; Rojas-Campos E; Martínez-Ramírez HR; Valera-González I; Medina M; Monteón F; Ruiz N; Becerra M; Palomeque MA; Cortés-Sanabria L
    Perit Dial Int; 2006; 26(3):341-8. PubMed ID: 16722027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experiences with nocturnal intermittent peritoneal dialysis].
    Brunkhorst R; Wrenger E; Koch KM
    Dtsch Med Wochenschr; 1993 Jan; 118(1-2):6-12. PubMed ID: 8420776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Continuous ambulatory peritoneal dialysis in children. 2 years' experience].
    Heller-Ackeret C; Ertelt W; Leumann EP
    Schweiz Med Wochenschr; 1982 Jun; 112(24):859-64. PubMed ID: 7051275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adequacy of solute and water removal in children treated with nightly intermittent peritoneal dialysis.
    Edefonti A; Picca M; Ghio L; Bassi S; Cattarelli D; Leccese V
    Adv Perit Dial; 1992; 8():402-5. PubMed ID: 1361833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nightly intermittent peritoneal dialysis to initiate peritoneal dialysis.
    Ramalakshmi S; Bernardini J; Piraino B
    Adv Perit Dial; 2003; 19():111-4. PubMed ID: 14763045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term successful nocturnal intermittent peritoneal dialysis: a ten-year case study.
    Trivedi HS; Twardowski ZJ
    Adv Perit Dial; 1994; 10():81-4. PubMed ID: 7999870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous ambulatory peritoneal dialysis: three years' experience.
    Ramos JM; Gokal R; Siamopolous K; Ward MK; Wilkinson R; Kerr DN
    Q J Med; 1983; 52(206):165-86. PubMed ID: 6611839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal comparison of intermittent versus continuous ambulatory peritoneal dialysis, in the same patients.
    Madden MA; Zimmerman SW; Simpson DP
    Clin Nephrol; 1981 Dec; 16(6):293-9. PubMed ID: 6797767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy cost and complication rate of APD and CAPD as long-term outpatient treatments for renal failure.
    King LK; Kingswood JC; Sharpstone P
    Adv Perit Dial; 1992; 8():123-6. PubMed ID: 1361767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability in calculations of dialysis adequacy in patients using nightly intermittent peritoneal dialysis compared to CAPD.
    Friedlander MA; Rahman M; Tessman MJ; Hanslik TM; Ferrara KA; Newman LN
    Adv Perit Dial; 1995; 11():93-6. PubMed ID: 8534747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dialysis adequacy indices in high membrane transporters treated with short-dwell peritoneal dialysis.
    Strauss FG; Holmes DL; Dennis RL
    Adv Perit Dial; 1995; 11():110-3. PubMed ID: 8534681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of the number of peritonitis episodes on peritoneal membrane function].
    Jovanović D; Nesić V; Dimitrijević Z
    Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypokalaemia: an independent risk factor of Enterobacteriaceae peritonitis in CAPD patients.
    Chuang YW; Shu KH; Yu TM; Cheng CH; Chen CH
    Nephrol Dial Transplant; 2009 May; 24(5):1603-8. PubMed ID: 19103738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Continuous ambulatory peritoneal dialysis (CAPD). 3 years' therapeutic experience in 100 patients].
    Rottembourg J; de Groc F; Jacq D; Issad B; El Shahat Y; Aqraflotis A; Seidler A; Legrain M
    Z Urol Nephrol; 1983 Mar; 76(3):191-201. PubMed ID: 6858416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing peritonitis in continuous ambulatory peritoneal dialysis patients versus automated peritoneal dialysis patients.
    Locatelli AJ; Marcos GM; Gómez MG; Alvarez SA; DeBenedetti LC
    Adv Perit Dial; 1999; 15():193-6. PubMed ID: 10682100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twelve months' experience with continuous ambulatory and intermittent peritoneal dialysis.
    Lacke C; Senekjian HO; Knight TF; Frazier M; Hatlelid R; Kozak M; Baker P; Weinman EJ
    Arch Intern Med; 1981 Feb; 141(2):187-90. PubMed ID: 7458514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal dialysis-associated peritonitis in Scotland (1999-2002).
    Kavanagh D; Prescott GJ; Mactier RA
    Nephrol Dial Transplant; 2004 Oct; 19(10):2584-91. PubMed ID: 15304559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome and survival in different peritoneal dialysis modalities.
    Al-Hilali N; Al-Humoud H; Nampoory M; Ninan A; Johny K
    Ther Apher Dial; 2007 Apr; 11(2):101-6. PubMed ID: 17381530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
    Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.